Insmed



Ebitda Veränderung Datum
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Cytokinetics USD -136657000 1.73M 2024-12
DBV Technologies USD -27409000 2.3M 2024-09
Dynavax Technologies USD 439K 11.7M 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Insmed USD -241795000 46.45M 2024-12
Novartis USD 6.82B 1.31B 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Insmed - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.